Piramal Pharma Quarterly Results for Trading Insights
PPLPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-99 Cr
QSept 2025
Piramal Pharma Quarterly Results Key Highlights
- Revenue of ₹2,124 Cr in Sept 2025 (-24.5% vs Mar 2025, -8.4% vs Sept 2024)
- Net Profit of ₹-99 Cr in Sept 2025 (-164.3% vs Mar 2025, -530.4% vs Sept 2024)
- EBITDA of ₹239 Cr in Sept 2025 (-61.4% vs Mar 2025)
- Operating Margin of 8.0% in Sept 2025 (-12.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.75 in Sept 2025 (-164.7% vs Mar 2025)
Piramal Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,124 | 2,812 | 2,031 | 2,320 | 2,591 | -24.5% | -8.4% |
| Net Profit (₹ Cr) | -99 | 154 | -82 | 23 | 101 | - | - |
| EBITDA (₹ Cr) | 239 | 619 | 204 | 420 | 538 | - | - |
| EPS (₹) | -0.75 | 1.16 | -0.62 | 0.17 | 0.77 | - | - |
| Operating Margin (%) | 8.0% | 20.0% | 6.0% | 15.0% | 20.0% | - | - |
Piramal Pharma Share Price Trend Around Quarterly Results
Visualize Piramal Pharma's 1-year price movement across quarterly results — ideal for logging trades in Piramal Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Piramal Pharma
Additional stock information and data for PPLPHARMA
Revenue Trend (₹ Cr)
Sept 2024
2,320
Jun 2025
2,031
Mar 2025
2,812
Sept 2025
2,124
Net Profit Trend (₹ Cr)
Sept 2024
23
Jun 2025
-82
Mar 2025
154
Sept 2025
-99
Operating Margin Trend (%)
Sept 2024
15.0%
Jun 2025
6.0%
Mar 2025
20.0%
Sept 2025
8.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Piramal Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores